|
1
|
Silvera D, Formenti SC and Schneider RJ:
Translational control in cancer. Nat Rev Cancer. 10:254–266. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dong ZZ and Zhang JT: Initiation factor
eIF3 and regulation of mRNA translation, cell growth, and cancer.
Crit Rev Oncol Hematol. 59:169–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hershey JW: Regulation of protein
synthesis and the role of eIF3 in cancer. Braz J Med Biol Res.
43:920–930. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buttitta F, Martella C, Barassi F,
Felicioni L, Salvatore S, Rosini S, D'Antuono T, Chella A, Mucilli
F, Sacco R, et al: Int6 expression can predict survival in
early-stage non-small cell lung cancer patients. Clin Cancer Res.
11:3198–3204. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cappuzzo F, Varella-Garcia M, Rossi E,
Gajapathy S, Valente M, Drabkin H and Gemmill R: MYC and EIF3H
coamplification significantly improve response and survival of
non-small cell lung cancer patients (NSCLC) treated with gefitinib.
J Thorac Oncol. 4:472–478. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Savinainen KJ, Helenius MA, Lehtonen HJ
and Visakorpi T: Overexpression of EIF3S3 promotes cancer cell
growth. Prostate. 66:1144–1150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lei YX, Wei L, Wang M, Wu GR and Li M:
Malignant transformation and abnormal expression of eukaryotic
initiation factor in bronchial epithelial cells induced by cadmium
chloride. Biomed Environ Sci. 21:332–338. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang L, Pan X and Hershey JW: Individual
overexpression of five subunits of human translation initiation
factor eIF3 promotes malignant transformation of immortal
fibroblast cells. J Biol Chem. 282:5790–5800. 2007. View Article : Google Scholar
|
|
9
|
Umar A, Kang H, Timmermans AM, Look MP,
Meijer-van Gelder ME, den Bakker MA, Jaitly N, Martens JW, Luider
TM, Foekens JA and Pasa-Tolić L: Identification of a putative
protein profile associated with tamoxifen therapy resistance in
breast cancer. Mol Cell Proteomics. 8:1278–1294. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Burnicka-Turek O, Kata A, Buyandelger B,
Ebermann L, Kramann N, Burfeind P, Hoyer-Fender S, Engel W and
Adham IM: Pelota interacts with HAX1, EIF3G and SRPX and the
resulting protein complexes are associated with the actin
cytoskeleton. BMC cell Biol. 11:282010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim JT, Lee SJ, Kim BY, Lee CH, Yeom YI,
Choe YK, Yoon DY, Chae SK, Kim JW, Yang Y, et al: Caspase-mediated
cleavage and DNase activity of the translation initiation factor 3,
subunit G (eIF3g). FEBS Lett. 587:3668–3674. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu F, Wang Y, Zeng S, Fu X, Wang L and
Cao J: Involvement of annexin A1 in multidrug resistance of
K562/ADR cells identified by the proteomic study. Omics.
13:467–476. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li C, Chen L, Ye J, Zhang X and Cao J:
Establishment of breast cancer cell models with inducible
differential eIF3g expressions. Xi Bao Sheng Wu Xue Za Zhi.
34:1226–1231. 2012.In Chinese.
|
|
14
|
Suzuki K, Bose P, Leong-Quong RY, Fujita
DJ and Riabowol K: REAP: A two minute cell fractionation method.
BMC Res Notes. 3:2942010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cokol M, Nair R and Rost B: Finding
nuclear localization signals. EMBO Rep. 1:411–415. 2000. View Article : Google Scholar
|
|
16
|
Block KL, Vornlocher HP and Hershey JW:
Characterization of cDNAs encoding the p44 and p35 subunits of
human translation initiation factor eIF3. J Biol Chem.
273:31901–31908. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park HS, Himmelbach A, Browning KS, Hohn T
and Ryabova LA: A plant viral 'reinitiation' factor interacts with
the host translational machinery. Cell. 106:723–733. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cuchalova L, Kouba T, Herrmannová A, Dányi
I, Chiu WL and Valásek L: The RNA recognition motif of eukaryotic
translation initiation factor 3g (eIF3g) is required for resumption
of scanning of posttermination ribosomes for reinitiation on GCN4
and together with eIF3i stimulates linear scanning. Mol Cell Biol.
30:4671–4686. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park HS, Browning KS, Hohn T and Ryabova
LA: Eucaryotic initiation factor 4B controls eIF3-mediated
ribosomal entry of viral reinitiation factor. EMBO J. 23:1381–1391.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ryabova L, Park HS and Hohn T: Control of
translation reini-tiation on the cauliflower mosaic virus (CaMV)
polycistronic RNA. Biochem Soc Trans. 32:592–596. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hou CL, Tang Cj, Roffler SR and Tang TK:
Protein 4.1R binding to eIF3-p44 suggests an interaction between
the cytoskeletal network and the translation apparatus. Blood.
96:747–753. 2000.PubMed/NCBI
|
|
22
|
Machuy N, Thiede B, Rajalingam K, Dimmler
C, Thieck O, Meyer TF and Rudel T: A global approach combining
proteome analysis and phenotypic screening with RNA interference
yields novel apoptosis regulators. Mol Cell Proteomics. 4:44–55.
2005. View Article : Google Scholar
|
|
23
|
Kim JT, Kim KD, Song EY, Lee HG, Kim JW,
Kim JW, Chae SK, Kim E, Lee MS, Yang Y and Lim JS:
Apoptosis-inducing factor (AIF) inhibits protein synthesis by
interacting with the eukaryotic translation initiation factor 3
subunit p44 (eIF3g). FEBS Lett. 580:6375–6383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carpenter B, MacKay C, Alnabulsi A, MacKay
M, Telfer C, Melvin WT and Murray GI: The roles of heterogeneous
nuclear ribonucleoproteins in tumour development and progression.
Biochim Biophys Acta. 1765:85–100. 2006.
|
|
25
|
Ford LP, Wright WE and Shay JW: A model
for heterogeneous nuclear ribonucleoproteins in telomere and
telomerase regulation. Oncogene. 21:580–583. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Göhring F and Fackelmayer FO: The
scaffold/matrix attachment region binding protein hnRNP-U (SAF-A)
is directly bound to chromosomal DNA in vivo: A chemical
cross-linking study. Biochemistry. 36:8276–8283. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kawano S, Miyaji M, Ichiyasu S, Tsutsui KM
and Tsutsui K: Regulation of DNA Topoisomerase IIbeta through
RNA-dependent association with heterogeneous nuclear
ribonucleoprotein U (hnRNP U). J Biol Chem. 285:26451–26460. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiao R, Tang P, Yang B, Huang J, Zhou Y,
Shao C, Li H, Sun H, Zhang Y and Fu XD: Nuclear matrix factor hnRNP
U/SAF-A exerts a global control of alternative splicing by
regulating U2 snRNP maturation. Mol Cell. 45:656–668. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yugami M, Kabe Y, Yamaguchi Y, Wada T and
Handa H: hnRNP-U enhances the expression of specific genes by
stabilizing mRNA. FEBS Lett. 581:1–7. 2007. View Article : Google Scholar
|
|
30
|
Hope NR and Murray GI: The expression
profile of RNA-binding proteins in primary and metastatic
colorectal cancer: Relationship of heterogeneous nuclear
ribonucleoproteins with prognosis. Hum Pathol. 42:393–402. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huebner K, Druck T, Croce CM and Thiesen
HJ: Twenty-seven nonoverlapping zinc finger cDNAs from human T
cells map to nine different chromosomes with apparent clustering.
Am J Hum Genet. 48:726–740. 1991.PubMed/NCBI
|
|
32
|
Bettinger BT, Gilbert DM and Amberg DC:
Actin up in the nucleus. Nat Rev Mol Cell Biol. 5:410–415. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kukalev A, Nord Y, Palmberg C, Bergman T
and Percipalle P: Actin and hnRNP U cooperate for productive
transcription by RNA polymerase II. Nat Struct Mol Biol.
12:238–244. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Obrdlik A, Kukalev A, Louvet E, Farrants
AK, Caputo L and Percipalle P: The histone acetyltransferase PCAF
associates with actin and hnRNP U for RNA polymerase II
transcription. Mol Cell Biol. 28:6342–6357. 2008. View Article : Google Scholar : PubMed/NCBI
|
